Debating whether the bond market's prediction of the Fed's raise in rates is all wrong, with Kevin Giddis, Morgan Keegan Fixed Income Capital Markets managing director and CNBC's Rick Santelli.
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.
Douglas Roberts, of ChannelCapitalResearch.com, and Dean Barber, of the Barber Financial Group, share their investment strategies and favorite sectors with CNBC.